Posts Topics Forums Images
Search videos from message boards Videos Search messages from microblogs Microblogs Search messages from imdb.com Imdb Search messages from yuku.com Yuku Search messages from lefora.com (free forums) Lefora
My account: Login | Sign Up
Loading... 

BoardReader
Sort by rss  Atom  |   RSS
Search IDEV Put Everywhere

Finance / IDEV (Indevus Pharmaceuticals Inc.) Put

Results 1 - 6 of 6 for IDEV/Put
 
Ahead of the Bell: Endo downgraded on drug delays Endo Pharma downgraded as analyst expects more spending due to delayed approval for drugs On 8:13 am EST, Monday December 7, 2009 Buzz up! 0 Print.NEW YORK (AP) -- An Oppenheimer analyst downgraded shares of Endo Pharmaceuticals Holdings Inc. Monday, pointing to regulatory delays for two of Endo's testosterone drug candidates. John Newman ...
http://investorshub.advfn.com/boards/board.aspx?board_id=6908
 
Ranking Healthcare Stocks YTD Performance Ranking | Company (Ticker) | Year-to-Date Performance 1 HeartWare International, Inc. (NASDAQ:HTWR) 8721.6% 2 Vasogen Inc. (USA) (NASDAQ:IPCI) 2344.3% 3 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 1956.0% 4 Human Genome Sciences (NASDAQ:HGSI) 1191.5% 5 Opexa Therapeutics Inc. (NASDAQ:OPXA) 979.0% 6 OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) 977.3% 7 Speedus...
http://investorshub.advfn.com/boards/board.aspx?board_id=3252
 
[b]Ranking Healthcare Stocks YTD Performance[/b] Ranking | Company (Ticker) | Year-to-Date Performance 1 HeartWare International, Inc. (NASDAQ:HTWR) 8721.6% 2 Vasogen Inc. (USA) (NASDAQ:IPCI) 2344.3% 3 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 1956.0% 4 Human Genome Sciences (NASDAQ:HGSI) 1191.5% 5 Opexa Therapeutics Inc. (NASDAQ:OPXA) 979.0% 6 OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) 977.3% 7 ...
http://investorshub.advfn.com/boards/board.aspx?board_id=1418
 
Endo 3Q profit falls on Indevus buyout costs Endo Pharmaceuticals' 3rd-quarter profit dips on buyout costs; pain drugs drive revenue On 8:07 am EDT, Thursday October 29, 2009 Buzz up! 0 Print.Companies:Endo Pharmaceuticals Holdings Inc. CHADDS FORD, Pa. (AP) -- Drug developer Endo Pharmaceuticals Holdings Inc. said Thursday its third-quarter profit plunged on charges mainly related to the buyout ...
http://investorshub.advfn.com/boards/board.aspx?board_id=6908
 
Quote: Originally Posted by marcus300 I know the release date is soon or from what ive read, but I didnt see anything about a smaller dose, there have been studies going on for 8 and 9yrs with 1000mgs and ive not seen anything regarding a smaller dose. I think if people are really happy with their HRT therapy treatment they should...
http://forums.steroid.com/forumdisplay.php?f=72
 
Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes Press Release Source: Endo Pharmaceuticals On Friday September 25, 2009, 9:02 am EDT Buzz up! 0 Print.Companies:Endo Pharmaceuticals Holdings Inc. CHADDS FORD, Pa., Sept. 25 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP - News) announced today the expiration and final results ...
http://investorshub.advfn.com/boards/board.aspx?board_id=6908
More discussions about IDEV
Trading
Buy
Sell
Report
Options
Analyst
Recommendation
Support Level
Put
Call
Discussions activity
 1